Similar articles

• Parsing the subsets: When small studies create confusion.

  Blankenship JC. Blankenship JC. Catheter Cardiovasc Interv. 2008 Jul 1;72(1):23-4. doi: 10.1002/ccd.21648. Catheter Cardiovasc Interv. 2008. PMID: 18561152 No abstract available.
• Late outcomes of drug-eluting versus bare metal stents in saphenous vein grafts: Propensity score analysis.

  Applegate RJ, Sacrinty M, Kutcher M, Santos R, Gandhi S, Little W. Applegate RJ, et al. Catheter Cardiovasc Interv. 2008 Jul 1;72(1):7-12. doi: 10.1002/ccd.21566. Catheter Cardiovasc Interv. 2008. PMID: 18412239
• Revitalizing embolic protection in saphenous vein grafts.

  Satler LF. Satler LF. Catheter Cardiovasc Interv. 2010 Aug 1;76(2):270-1. doi: 10.1002/ccd.22708. Catheter Cardiovasc Interv. 2010. PMID: 20665876 No abstract available.
• Approach to the patient with prior bypass surgery.

  Nguyen T, Pham L, Cheem TH, Douglas JS, Hermiller J, Grines C. Nguyen T, et al. J Interv Cardiol. 2004 Oct;17(5):339-46. doi: 10.1111/j.1540-8183.2004.04033.x. J Interv Cardiol. 2004. PMID: 15491339 Review. No abstract available.
• The use of drug-eluting stents in venous coronary artery bypass grafts.

  Hernandez-Antolín R, Alfonso F, Jimenez P. Hernandez-Antolín R, et al. EuroIntervention. 2009 May;5 Suppl D:D51-7. EuroIntervention. 2009. PMID: 19736072 Review.